• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Connell broadens offering to its Life Science customers with the acquisition of Ingredient Resources

Share:

May 20, 2019

Connell, a Wilbur-Ellis company and a leading marketer and distributor of specialty chemicals and ingredients in Asia-Pacific, announces today the acquisition of Ingredient Resources Pty Limited, a supplier and distributor of innovative, valued-added ingredients in Australia and New Zealand. Ingredient Resources supplies numerous first-class manufacturers in the food and beverage, confectionery, flavor and fragrance, cosmetic, healthcare and pharmaceutical industries.

With this acquisition, Connell expands its ability to offer its customers state-of-the-art solutions with Ingredient Resources’ highly specialized product range and innovative ingredients, benefitting its customers far beyond Australia and New Zealand. This acquisition enhances Connell’s formulation advice and technical support to create unique offerings for its customers and end users.

“This acquisition represents a unique opportunity for us to further solidify our relationships with our customers through expanded ingredients offerings that can help them with new product development,” said Connell President and CEO, Dr. Azita Owlia. She added that Ingredient Resources will bring new long-term relationships with international ingredient suppliers that are at the forefront of ingredient technology.

Connell will reaffirm its premier position in the life science space with this acquisition. “Acquiring the Ingredient Resources business, with its exclusive partnerships with world-class supply partners, is very exciting,” said Connell Australasia General Manager Graham Brown. “I’m excited to work closely with Ingredient Resources’ Founder and CEO Dennis Chesser who brings extensive expertise and market knowledge. This acquisition strengthens our market position in the food, nutrition and nutraceuticals markets, while reinforcing our commitment to the Australasian market.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Joining Connell brings greater financial stability to grow the “value-added” ingredient business, ably supported by our international supply partners,” shared Ingredient Resources Founder and CEO Dennis Chesser. “We are proud to join Connell, a strong and dynamic organization with a 120-year history of continuous growth in the Asia-Pacific region.”

Date: May 20, 2019

Source: Cision

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • COVID-19: Is Your Hospital’s Supply Chain Ready for Coronavirus?COVID-19: Is Your Hospital’s Supply Chain Ready for Coronavirus?
  • Venture Capital Funding in Digital Health Startups Reaches $8.9 Billion in 2019, ReportVenture Capital Funding in Digital Health Startups Reaches $8.9 Billion in 2019, Report
  • AliveCor and Clario Partner to Offer Decentralized Clinical Trials- Focused Six-Lead ECG SolutionsAliveCor and Clario Partner to Offer Decentralized Clinical Trials- Focused Six-Lead ECG Solutions
  • The Worldwide Breast Reconstruction Industry is Expected to Reach $647 Million By 2026The Worldwide Breast Reconstruction Industry is Expected to Reach $647 Million By 2026
  • Innovaccer Launches Perioperative Optimization Platform for SurgeonsInnovaccer Launches Perioperative Optimization Platform for Surgeons
  • Blockchain 3.0 and COTI – Next Generation Technology Without Mining?Blockchain 3.0 and COTI – Next Generation Technology Without Mining?
  • EarlySign Unveils Industrial Availability of AI Diabetes Danger Predictors AlgorithmEarlySign Unveils Industrial Availability of AI Diabetes Danger Predictors Algorithm
  • BridgeBio Pharma and Eidos Therapeutics Announce Merger AgreementBridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications